06/05/2024 3:10 PM | BIENAIME JEAN JACQUES (Reporting) Keros Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/05/2024 3:11 PM | BIENAIME JEAN JACQUES (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/03/2024 3:15 PM | Farzan Nima (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:15 PM | GORDON CARL L (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:15 PM | GRAY MARY ANN (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:15 PM | Keros Therapeutics (Issuer) Knowles Julius (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/03/2024 3:15 PM | Keros Therapeutics (Issuer) Nussbaum Ran (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:15 PM | Kariv Tomer (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:15 PM | Keros Therapeutics (Issuer) Seth Alpna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 7:03 AM | Keros Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024 7:00 AM | Keros Therapeutics (Filer)
| Form S-3ASR | |
03/14/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 7:02 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 3:02 PM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/15/2024 7:37 PM | Cooper Simon Peter (Reporting) Keros Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 7:38 PM | Keros Therapeutics (Issuer) Rovaldi Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 7:40 PM | Keros Therapeutics (Issuer) Regnante Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 7:41 PM | Keros Therapeutics (Issuer) Seehra Jasbir (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:38 PM | ALKEON CAPITAL MANAGEMENT LLC (Filed by) Keros Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 8:16 AM | FMR LLC (Filed by) Keros Therapeutics (Subject)
| Form SC 13G/A | |
01/26/2024 4:26 PM | BlackRock Inc. (Filed by) Keros Therapeutics (Subject)
| Form SC 13G/A | |
01/09/2024 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 3:43 PM | Keros Therapeutics (Issuer) Regnante Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:02 PM | Keros Therapeutics (Filer)
| Form 424B5 | |
01/04/2024 3:04 PM | Keros Therapeutics (Subject) Regnante Keith (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 3:04 PM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 7:04 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/13/2023 4:20 PM | Keros Therapeutics (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
12/11/2023 5:44 PM | Keros Therapeutics (Subject) ORBIMED CAPITAL LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 5:02 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 7:06 AM | Keros Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023 7:11 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2023 7:02 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Elon to Transform U.S. Economy? (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
08/07/2023 7:00 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2023 7:04 AM | Keros Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2023 7:01 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/09/2023 5:02 AM | Keros Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |